Paediatric Infectious Diseases

Prof. Dr. Nazan Dalgıç

COVID-19Influenza, HumanDiarrheaChickenpoxSepsisTuberculosisCross InfectionCoughHydrocephalusMeaslesGastroenteritisMeningitis, BacterialProsthesis-Related InfectionsMeningomyeloceleMycosesUrinary Tract InfectionsDiarrhea, InfantileTuberculosis, Pulmonary

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Influenza, Human 4 publications
  • Diarrhea 4 publications
  • Chickenpox 4 publications
  • Sepsis 4 publications
  • Tuberculosis 4 publications
  • Cross Infection 4 publications
  • Cough 3 publications
  • Hydrocephalus 3 publications
  • Measles 2 publications
  • Gastroenteritis 2 publications
  • Meningitis, Bacterial 2 publications
  • Prosthesis-Related Infections 2 publications
  • Meningomyelocele 2 publications
  • Mycoses 2 publications
  • Urinary Tract Infections 2 publications
  • Diarrhea, Infantile 2 publications
  • Tuberculosis, Pulmonary 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPaediatric Infectious Diseasessaglik.gov.trFrom source
  • InstitutionŞişli Hamidiye Etfal Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 9 publications · Model version —From source
  • Publications152 publicationsOpenAlex, Europe PMCFrom source
  • ORCID0000-0002-6516-8897ORCIDFrom source
  • Last synchronised5 November 2026 08:56https://sislietfaleah.saglik.gov.tr/TR-1434028/doktorlarimiz.html#nazan-dalgicsaglik.gov.tr

Scientific work

Publications on COVID-19

152 publications
  1. Clinical characteristics and predictors of severe pertussis in hospitalized children after the COVID-19 period in Türkiye: a multicenter study

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07206-9 PMID 42448840 Source: OpenAlex

  2. Pediatric invasive meningococcal disease in Türkiye during the post-pandemic period: increased reported cases and predominance of serogroup B and severity determined by a clinical form in a multicenter hospital-based cohort

    European journal of pediatrics, 2026

    DOI 10.1007/s00431-026-07399-z PMID 42802197 Source: Europe PMC

  3. Influenza-associated neurological complications in pediatric patients: clinical characteristics, outcomes, and the neuroinfluenza severity score in the multicenter TURK-INF study

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07411-6 PMID 42745076 Open-access full textSource: OpenAlex

  4. Cryptococcus neoformans Peritonitis in a Child With Schimke Immuno-osseous Dysplasia: A Case Report

    The Pediatric infectious disease journal, 2026

    DOI 10.1097/inf.0000000000005411 PMID 42723135 Source: Europe PMC

  5. Should we leave paediatric emergency triage to artificial intelligence? A comparison of ChatGPT 4o and Grok 3

    Frontiers in Pediatrics, 2026

    DOI 10.3389/fped.2026.1739217 PMID 41782959 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  6. Influenza vaccination rates in children: a multicenter nationwide study

    The Turkish Journal of Pediatrics, 2026

    DOI 10.24953/turkjpediatr.2026.6651 PMID 42172456 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Pediatric brucellosis: predictors of hospitalization, complications, and relapse in a nationwide multicenter cohort

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07334-2 PMID 42603185 1 citation (OpenAlex) Source: OpenAlex

  8. Investigation of high-risk Escherichia coli ST131 clone carriage in healthy children

    Reviews in Medical Microbiology, 2026

    DOI 10.1097/mrm.0000000000000450 1 citation (OpenAlex) Source: OpenAlex

  9. Evaluation of Pediatric Patients Diagnosed with Encephalitis: Single Center Experience

    SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital, 2026

    DOI 10.14744/semb.2026.03295 PMID 42428711 Open-access full textSource: OpenAlex

  10. Phase 2/3, Open-label, Randomized, Active-controlled Clinical Trial Evaluating the Safety and Efficacy of Imipenem/Cilastatin/Relebactam in Pediatric Patients From Birth to Less Than 18 Years With Gram-negative Bacterial Infections

    The Pediatric Infectious Disease Journal, 2026

    DOI 10.1097/inf.0000000000005323 PMID 42400209 Open-access full textSource: OpenAlex

View all 152 publications